J Müller Selected Research

J Müller Research Topics

Disease

11	Neoplasms (Cancer) 01/2016 - 07/2000
4	Pain (Aches) 09/2015 - 07/2000
4	Dystonia (Limb Dystonia) 05/2004 - 07/2000
4	Brain Neoplasms (Brain Tumor) 07/2003 - 01/2000
4	Torticollis (Wryneck) 07/2002 - 01/2001
3	Seminoma 04/2014 - 03/2011
3	Lymphoma (Lymphomas) 06/2012 - 12/2001
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 07/2003 - 01/2002
3	Dystonic Disorders (Writer's Cramp) 09/2002 - 01/2001
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2001 - 02/2000
3	Precocious Puberty 07/2000 - 01/2000
2	Hypoxia (Hypoxemia) 01/2023 - 02/2015
2	Asthma (Bronchial Asthma) 01/2023 - 06/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2013
2	Deafness (Deaf Mutism) 07/2017 - 12/2003
2	Inflammation (Inflammations) 09/2015 - 07/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 02/2000
2	Residual Neoplasm 04/2014 - 03/2011
2	Osteoarthritis 08/2013 - 03/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2012 - 12/2011
2	Heart Failure 02/2012 - 02/2000
2	Myocardial Infarction 02/2012 - 02/2000
2	Hypertension (High Blood Pressure) 02/2012 - 02/2000
2	Wounds and Injuries (Trauma) 12/2011 - 03/2000
2	Necrosis 08/2011 - 03/2005
2	Hearing Loss (Hearing Impairment) 01/2010 - 12/2003
2	Breast Neoplasms (Breast Cancer) 01/2005 - 12/2003
2	Arthritis (Polyarthritis) 03/2004 - 01/2002
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2002 - 11/2000
2	Allergic Bronchopulmonary Aspergillosis 07/2002 - 01/2002
2	Cystic Fibrosis (Mucoviscidosis) 07/2002 - 01/2002
2	Cushing Syndrome 07/2002 - 01/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2001 - 06/2001
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2001 - 01/2001
1	Pulmonary Hypertension 01/2023
1	Pulmonary Arterial Hypertension 01/2023
1	Hyperventilation 01/2023
1	Vascular Diseases (Vascular Disease) 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Acidosis 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Melanoma (Melanoma, Malignant) 02/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2019
1	Multiple Myeloma 01/2017
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Ependymoma 01/2016
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2016
1	Neurilemmoma (Schwannoma) 01/2016
1	Meningioma (Meningiomas) 01/2016
1	Activated Protein C Resistance (APC Resistance) 01/2016
1	Onychomycosis (Tinea Unguium) 10/2015
1	Fever (Fevers) 09/2015

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 06/2012 - 01/2001
5	Type A Botulinum Toxins (Botox)FDA Link 07/2002 - 07/2000
3	Botulinum Toxins (Botulinum Toxin)IBA 05/2004 - 09/2001
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2000 - 01/2000
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 07/2000 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2006
2	willow bark extractIBA 09/2015 - 08/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2010 - 12/2001
2	Prednisolone (Predate)FDA LinkGeneric 02/2010 - 01/2003
2	CopperIBA 09/2002 - 12/2001
2	Itraconazole (Sporanox)FDA LinkGeneric 07/2002 - 01/2002
2	Budesonide (Pulmicort)FDA LinkGeneric 07/2002 - 01/2002
2	Insulin (Novolin)FDA Link 01/2002 - 08/2000
2	SteroidsIBA 01/2002 - 02/2000
2	abobotulinumtoxinA FDA Link 12/2001 - 01/2001
2	Growth Hormone (Somatotropin)IBA 12/2001 - 01/2000
2	Immunoglobulins (Immunoglobulin)IBA 07/2001 - 02/2000
2	inhibin BIBA 06/2001 - 01/2000
2	AutoantibodiesIBA 05/2000 - 02/2000
1	Carbonic Anhydrase InhibitorsIBA 01/2023
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2023
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2023
1	Bronchodilator Agents (Bronchodilators)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2020
1	Nonesterified Fatty Acids (NEFA)IBA 02/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2020
1	Bortezomib (Velcade)FDA Link 01/2017
1	Thrombin FDA Link 01/2016
1	MitogensIBA 01/2016
1	Neurofibromin 2 (Merlin)IBA 01/2016
1	KSR-1 protein kinaseIBA 01/2016
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2016
1	factor V LeidenIBA 01/2016
1	Protein CIBA 01/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2016
1	Ciclopirox (Loprox)FDA LinkGeneric 10/2015
1	amorolfineIBA 10/2015

Therapy/Procedure

23	Therapeutics 01/2021 - 01/2000
11	Drug Therapy (Chemotherapy) 05/2019 - 06/2001
5	Radiotherapy 04/2014 - 06/2001
5	Cranial Irradiation 07/2003 - 01/2000
3	Aftercare (After-Treatment) 01/2021 - 06/2001
3	Cochlear Implantation 09/2007 - 11/2002
3	Injections 03/2002 - 07/2000
2	Cochlear Implants (Cochlear Implant) 07/2017 - 11/2002
2	Chemoradiotherapy 01/2001 - 01/2001
1	Endurance Training 05/2019